Wireless pacemakers under the microscope: french registry tracks Real-World safety

NCT ID NCT06262295

Recruiting now Disease control Sponsor: French Cardiology Society Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This French registry will follow 1000 patients who receive AVEIR leadless pacemakers to see how safe and effective they are in everyday use. Unlike traditional pacemakers, these devices are placed directly in the heart without wires, which may reduce complications and improve comfort. The study will track implantation success, device longevity, and any problems that arise.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AVEIR VR LP and AVEIR AR LP leadless pacemakers
What this could lead to: If successful, this registry could confirm that leadless pacemakers are safe and effective in routine use, potentially reducing complications and improving comfort for people needing a pacemaker.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove the device works better than alternatives. Results may not apply to all patients, and rare complications may still emerge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PACEMAKER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PACEMAKER

Contacts and locations

Locations

Chu de Grenoble - Hopital Michallon
RECRUITING

La Tronche, 38700, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.